Current stock page

Financial Data

VCEL Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Nov 13, 2026

VCELVericel Corporation

Healthcare / Biotechnology

Leader

Sector Leader

BullishEdge 10/10
$56.96−$0.46 (−0.80%)

Latest quote

  • Momentum
    90
  • Value
    65
  • Quality
    76
  • Risk resilience
    64
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Nov 16, 2026.

Income statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Revenue$85.37M$77.46M$68.43M$92.92M$67.5M$63.24M$52.6M$75.38M
Gross Profit$62.61M$56.4M$49.27M$73.13M$49.59M$46.61M$36.27M$58.5M
Operating Income$12.19M$434K-$8.06M$22.42M$3.45M-$2.03M-$12.79M$18.48M
Net Income$14.16M$2.21M-$6.3M$23.24M$5.07M-$553K-$11.25M$19.81M
EPS$0.28$0.04-$0.12$0.46$0.1-$0.01-$0.23$0.4
Cash flow statement
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Operating Cash Flow$17.72M$16.19M$16.38M$15.01M$22.08M$8.21M$6.6M$22.24M
Capital Expenditure-$2.04M-$1.93M-$1.26M-$14.21M-$2.63M$14.21M-$14.21M-$13.79M
Free Cash Flow$15.68M$14.26M$15.13M$802K$19.45M$22.43M-$7.61M$8.46M
Net Cash Provided By Operating Activities$17.72M$16.19M$16.38M$15.01M$22.08M$8.21M$6.6M$22.24M
Balance sheet
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Assets$517.11M$502.87M$485.63M$487.97M$453.27M$435.61M$424.59M$432.72M
Total Debt$91.15M$92.54M$94.54M$98.27M$98.01M$99.76M$98.97M$98.85M
Cash And Cash Equivalents$133.49M$125.36M$109.3M$100.09M$100.4M$80.53M$73.49M$74.52M
Total Liabilities$132.94M$132.83M$129.4M$133.33M$131.42M$128.8M$129.1M$140.76M
Total Stockholders Equity$384.17M$370.04M$356.23M$354.64M$321.86M$306.81M$295.49M$291.97M
Key financial metrics
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio86.85100.183.11118.78153.76247.62701.65250.02
P/B ratio7.536.555.015.536.255.747.078.87
P/S ratio8.99———————
Debt To Equity0.240.250.270.280.30.330.330.34
Free Cash Flow Yield1.59%2.05%3.24%1.79%2.12%3.65%2.09%1.71%
Financial ratios
8 periods
Metric2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
P/E ratio86.85100.183.11118.78153.76247.62701.65250.02
P/B ratio7.536.555.015.536.255.747.078.87
P/S ratio8.99———————
Return On Equity8.67%6.55%6.02%4.66%4.06%2.32%1.01%3.55%
Debt To Equity0.240.250.270.280.30.330.330.34

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
Pe86.3x
Pb7.59x
Revenue Growth Yoy26.47%
EPS Growth Yoy180.00%
Gross Margin74.47%
Operating Margin8.32%
ROE9.09%
ROIC5.51%
Debt To Equity0.24
FCF Yield1.58%

As of Nov 13, 2026

Technical indicators
MetricValue
Close$56.96
Volume698,792
RSI (14)73.46
MACD4.56
MACD signal3.07
MACD histogram1.49
ADX (14)35.86
SMA (50)$42.78
SMA (200)$39.40
ATR (14)$2.51
Historical volatility (annualized)76.56%
Volume (20-day average)910,061

As of Nov 13, 2026

Risk measures
MetricValue
Resilience score64/100
Beta0.52
Annual volatility45.04%
Max Drawdown-31.03%
Sharpe Ratio0.93
VaR (95%, 1-day)-4.28%

As of Nov 13, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

VCEL Financial Data FAQ

What is Vericel Corporation's revenue?

Vericel Corporation's revenue is one of the core financial data points for VCEL. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Vericel Corporation's revenue growing?

Revenue growth shows whether Vericel Corporation is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is VCEL's EPS?

VCEL's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Vericel Corporation's net income?

Vericel Corporation's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Vericel Corporation generate?

Free cash flow shows how much cash Vericel Corporation generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Vericel Corporation have?

Cash and debt help frame VCEL's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.